Influenza virus characterisation, summary Europe, April 2020
ECDC’s influenza virus characterisation reports are published periodically and give an overview of circulating influenza viruses. They provide details on the current vaccine strains, summarise the development of the viruses since the last report, and closely follow the main developments for the ongoing influenza season. Virus characterisation reports are primarily intended for influenza virologists and epidemiologists.
Weekly influenza update, week 8, February 2020
In collaboration with WHO Regional Office for Europe, ECDC monitors and reports on influenza activity in Europe on a weekly basis throughout the flu season.
Joint WHO/ECDC influenza virus characterisation report, summary of TESSy virus characterisation data 2017/18
Summary of influenza virus characterisation data reported by national influenza centres to The European Surveillance System for weeks 40/2017 to 20/2018.
Influenza virus characterisation, Summary Europe, June 2018
This is the sixth report of the 2017–18 influenza season. As of week 25/2018, nearly 239 000 influenza detections across the WHO European Region have been reported.
Influenza virus characterisation, Summary Europe, May 2018
This is the fifth report of the 2017–18 influenza season. As of week 20/2018, nearly 240 000 influenza detections across the WHO Europe region have been reported.
Joint WHO/Europe–ECDC Annual European Influenza Surveillance Meeting, 2018
The joint annual influenza surveillance meeting by ECDC and the WHO Regional Office for Europe took place on 6 - 8 June 2018 in Copenhagen, Denmark. Invited participants were epidemiological and virological surveillance experts nominated by national health authorities as well as representatives from international institutions, covering the 53 countries of the EU/EEA and the WHO European region. The meeting was by invitation only.
Influenza virus characterisation, Summary Europe, March 2018
The ECDC Influenza Virus Characterisations Reports are published periodically and provides an overview of the technical details of the circulating influenza viruses, such as antigenic and genetic properties, with a reference to the current vaccine strains. It also summaries the developments of the viruses since the last report, as well as the main developments for the ongoing season.